Matt Calistri | Vice President of Corporate Strategy and Investor Relations |
Tony Coles | Chairperson and Chief Executive Officer |
Ray Sanchez | Chief Medical Officer |
John Renger | Chief Scientific Officer |
Mark Bodenrader | Interim Chief Financial Officer |
A. Ceesay | President |
Michael Yee | Jefferies |
Matthew Harrison | Morgan Stanley |
Paul Matteis | Stifel |
Tiffany Sun | JPMorgan |
Douglas Tsao | H.C. Wainwright |
Graig Suvannavejh | Mizuho |
Good morning. And welcome to the Cerevel Therapeutics Second Quarter 2022 Financial Results Conference Call. At this time, all participants are in listen-only mode. Later, you will have the opportunity to ask questions during the Q&A portion of the call. Please note that this call may be recorded.